Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 9Sarcoma 3Thoracic 2CNS 2Other solid neoplasm 1Head & Neck 1Gynecologic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Neuroblastoma 60Central Nervous System Neoplasms 39Brain Neoplasms 34Medulloblastoma 26Astrocytoma 15Rhabdoid Tumor 12Glioblastoma 12Ependymoma 12Sarcoma 10Glioma 9Testicular Neoplasms 8Oligodendroglioma 7Choroid Plexus Neoplasms 7Teratoma 6Optic Nerve Glioma 6Neuroectodermal Tumors, Primitive, Peripheral 6Gliosarcoma 6Testicular Germ Cell Tumor 5Retinoblastoma 5Neuroectodermal Tumors, Primitive 5Neoplasms 5Lymphoma 5Recurrence 4Ovarian Neoplasms 4Ganglioneuroblastoma 4Familial ependymoma 4Carcinoma, Renal Cell 4Spinal Cord Neoplasms 3Rhabdomyosarcoma 3Osteosarcoma 3

Interventions

Filgrastim 7Carboplatin 5Thiotepa 3Temozolomide 3Peripheral Blood Stem Cell Transplantation 3Ifosfamide 3sargramostim 2motexafin gadolinium 2etoposide phosphate 2Sunitinib 2Radiosurgery 2Paclitaxel 2Melphalan 2Immunohistochemistry 2Granulocyte Colony-Stimulating Factor 2Gene Expression Profiling 2Etoposide 2Busulfan 2Amplified Fragment Length Polymorphism Analysis 2Amifostine 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1tanespimycin 1pentetreotide 1pembrolizumab 1oblimersen 1liposomal doxorubicin 1ixabepilone 1guadecitabine 1gallium Ga 68 dotatate 1erythromycin propionate-N-acetylcysteinate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Kidney Neoplasms × Etoposide × CNS × Clear all
NCT00623077 2017-12-05

MT2004-30: Tomotherapy for Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
23 enrolled
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Familial ependymoma, Astrocytoma, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor, Optic Nerve Glioma

NCT00003657 2017-01-20

High-dose ICE With Amifostine

Dana-Farber Cancer Institute

Phase 2 Completed
24 enrolled
CNSGenitourinaryGynecologicHead & NeckSarcomaThoracic

AIDS-related Kaposi sarcoma, Testicular Germ Cell Tumor, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Unknown Primary, Ovarian Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡